Each point was worked out with the data available that day. Scale 0-10: 5 is the index average and 10 is the cap (+3 standard deviations), not perfection. The vertical axis zooms to fit this company, so two charts are not comparable by eye.
Market and Valuation
Price & Market
Prev Close Price:$410.41
Open:$407.87
Day's Low:$407.36
Day's High:$422.65
Bid / Ask:-
Market Cap:50.18B
Enterprise Value:40.22B
52-Week Range
52-Week Low:$163.11
52-Week High:$456.50
Current position in 52-week range
52w Low-52w High
50-Day Avg:$401.66
200-Day Avg:$308.97
Volume
Volume Today:1,368,425
Avg Volume (3m):1,241,623
Avg Volume (10d):1,237,800
52-Week Change:+45.60%
vs S&P 500, 52 weeks:-
Beta:0.64
Valuation Multiples
P/E (trailing):39.46
Diluted EPS for the last 12 months: the four quarters ended Jun 30, 2026, from the accounts filed with the SEC on Jul 29, 2026. The P/E is the price divided by that EPS.
P/E (forward):24.45
PEG Ratio:1.13
Price / Book:2.61
Price / Sales (TTM):0.34
EV / Revenue:0.28
EV / EBITDA:11.18
Dividends
Current yield:0.86%
Annual Dividend Rate:$3.54
Dividend Trailing:$3.54
Yield Trailing:0.86%
5-Year Avg Yield:0.87%
Payout Ratio:33.46%
Last Ex-Dividend Date:-
Valuation Context
P/E vs sector (indicative)
Most Recent Quarter:-
Fiscal Year (Next):-
Loading historical OHLCV database...
Date
Open
High
Low
Close
Volume
Financial Statements TTM (Trailing 12 Months)
Income Statement
Total Revenue (TTM):145.68B
Gross Profit:19.89B
EBITDA:3.60B
Net Income (TTM):1.28B
Rev Growth (YoY):+26.20%
Earnings Growth (YoY):+27.10%
Quarterly earnings growth (YoY):+27.30%
Margins
Gross Margin:-
EBITDA Margin:-
Operating Margin:-
Net Margin:-
Per Share
EPS Trailing (TTM):$10.59
Diluted EPS for the last 12 months: the four quarters ended Jun 30, 2026, from the accounts filed with the SEC on Jul 29, 2026. The P/E is the price divided by that EPS.
EPS Forward (Est.):$17.09
Revenue Per Share:$1,211.44
Cash Per Share:-
Book Value:$160.00
Last Dividend:-
Ex-Dividend Date:-
Last Split:-
Balance Sheet & Liquidity
Total cash:23.87B
Total Debt:14.74B
Net Debt (Debt - Cash):−9.13B (net cash)
Debt / Equity:76.49%
Current Ratio:1.74
Quick Ratio:1.29
Cash Flows
Operating Cash Flow:2.54B
Free Cash Flow (FCF):1.94B
FCF Yield (FCF / Market Cap):-
Enterprise Value:40.22B
EV / Revenue:0.28
EV / EBITDA:11.18
Profitability
ROE (Return on Equity):6.89%
ROA (Return on Assets):3.90%
P/E (trailing):39.46
P/E (forward):24.45
Price / Book:2.61
PEG Ratio:1.13
52-Week Change:+45.60%
S&P 500 change, 52 weeks:+11.37%
Historical Evolution (Last 4 Years)
Income Statement
Balance Sheet
Cash Flow
EPS and Earnings Per Share
Key EPS Metrics
EPS Trailing (TTM):$10.59
Diluted EPS for the last 12 months: the four quarters ended Jun 30, 2026, from the accounts filed with the SEC on Jul 29, 2026. The P/E is the price divided by that EPS.
EPS Forward (Est.):$17.09
P/E (forward):24.45
PEG Ratio:1.13
Growth and Margins
Earnings Growth YoY:-
Quarterly Earnings Growth YoY:-
Rev Growth YoY:-
Net Margin:-
Gross Margin:-
EBITDA Margin:-
Per Share
Revenue Per Share:$1,211.44
Cash Per Share:-
Book Value:$160.00
Cash Flows (TTM)
Free Cash Flow:1.94B
Operating Cash Flow:2.54B
EBITDA:3.60B
Total Revenue (TTM):145.68B
Net Income (TTM):1.28B
Fiscal Year (Last):-
EPS Surprise History - Last 4 Quarters
Actual vs. Analyst Estimates · Green = beat expectations · Red = missed
Quarter
Period
Actual EPS
Estimated EPS
Difference
Surprise %
Currency
Ownership Structure
Ownership Distribution
% Insiders:-
% Institutional:-
% Inst. (of Float):-
No. of Institutions:-
Visual distribution
InsidersInstitutionalFree Float
Shares & Short Interest
Shares Outstanding:120,080,308
Float (free shares):119,826,939
Short interest (shares):3,665,781
Short % of float:-
Short Ratio (days to cover):2.41
Short interest, prior month:-
Short Interest Date:-
Governance Score (1=Best, 10=Worst)
Overall risk:-
Audit Risk:-
Board risk:-
Compensation Risk:-
Shareholder rights risk:-
Top Institutional Holders
Position Change: ▲ Increased · ▼ Reduced · = Unchanged
Organization
Report Date
% Shares
No. Shares
Value (USD)
Change %
Top Mutual Funds
Position Change: ▲ Increased ▼ Decreased = Unchanged
Fund
Report Date
% Shares
No. Shares
Value (USD)
Change %
Recent Insider Trades
Executive / Insider
Title
Date
Action
Shares
Options Chain
CALLS
Strike
Last
Bid
Ask
Vol.
O.I.
IV
PUTS
Strike
Last
Bid
Ask
Vol.
O.I.
IV
Sentiment Metrics
Put/Call Ratio (Volume):-
Put/Call Ratio (O.I.):-
Max Pain (estimated):-
Total O.I. Calls:-
Total O.I. Puts:-
Expected move
Average IV (Calls ATM):-
Average IV (Puts ATM):-
Days to Expiration:-
Expected move (±):-
Humana Inc. (HUM) SEC filings: 10-K, 10-Q and 8-K
Direct links to financial reports filed with the SEC.
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
A free account saves your simulator portfolios, your personal portfolio and your Academy progress, synced across devices. And, if you switch it on, the email alert the same day an insider buys stock in their own company.
No card. No spam.
Humana Inc. (HUM): Quantitative Analysis
Humana Inc. (HUM) — Healthcare — Healthcare Plans. HUM is in the S&P 500 today. Model factor scores and market data, recalculated every trading day.
So far in 2026, HUM has returned +64.2% against +11.4% for the S&P 500 (SPY): total return, dividends included on both sides, from Dec 31, 2025 to Nov 3, 2026.
HUM ranks 127 of 461 on today's multifactor score, and 12 of the 55 Healthcare companies that score. Its strongest factor is value (Z 0.91, ranked 49 of 489); its weakest is quality (Z -0.54, ranked 400 of 468). Each factor ranks only the companies with data for it, and the multifactor score only those with all four: that is why the totals differ.
Factor scores
The Z-Score is how many standard deviations the company sits from the index average: 0 is average, positive is better than average, negative is worse.
According to Nasdaq's public calendar (checked on Nov 4, 2026), Humana will report its next earnings on Nov 6, 2026, before the US market opens. The date is announced by the company itself and can change. Of its last 12 earnings announcements: 12 before the open (SEC filings through Jul 29, 2026). HUM earnings dates and times, quarter by quarter →
What is Humana's P/E ratio?
Humana's P/E (price over earnings per share for the last twelve months) is 39.5 at the Nov 3, 2026 close. That EPS is the 12-month diluted figure from the SEC, the four quarters ended Jun 30, 2026. The median of the 54 Healthcare companies with a P/E is 30.5, and the S&P 500's, 23.5: Humana is above its sector median. Healthcare stocks, company by company →
Where does Humana rank on Quant500?
In the Nov 3, 2026 multi-factor ranking, Humana ranks 127 of 461, and 12 of the 55 Healthcare companies that score. The ranking orders S&P 500 companies by the average of four factors (momentum, value, quality and growth) and is recalculated every trading day. It is a model output, not investment advice. The full ranking →How it is calculated →
Have Humana insiders bought or sold shares?
The latest open-market purchase of Humana shares filed with the SEC (Form 4) was on Feb 23, 2026, by an officer, for $150k. Nor any open-market sale. In total, from August 2025 through Nov 3, 2026: 1 purchase and 0 sales by directors, officers and large shareholders. All HUM insider trades →
Does Humana pay a dividend?
Yes. Its dividend yield is 0.86% at the Nov 3, 2026 close (annual dividend of $3.54 per share). The next announced ex-dividend date is Dec 24, 2026.
What sector is Humana in, and which index?
Humana is classified in the Healthcare sector (industry: Healthcare Plans), per the data provider's classification (similar to GICS, not identical). It is in the S&P 500 today. It is one of the 59 S&P 500 companies in that sector. Healthcare stocks →
What is behind these numbers
The concepts on this page, explained from scratch in the Academy. Free, no account.
Quality and low volatilityWhere the quality score comes from, and why it is the factor with the most competing definitions, all of them called the same thing.
We save the portfolios you design, your own portfolio and your Academy progress, synced across devices.
Free, no card. Two automatic emails and no more: the one that confirms your address and the welcome one. After that, nothing you do not switch on yourself in your profile — such as the alert for insider buys, the same day they are reported to the SEC.